Importantly, despite these suppressive effects exerted on the pro-tumor mediator IL-8, an unwanted consequence of this targeted drug-induced therapy was, in turn, the expression of CD271, a marker of melanoma stem-like cells. The gene discussed is CXCL8; the disease is melanoma.